The efficacy and safety of newer anticonvulsants in patients with dementia

Drugs and Aging

Volumn 29, Issue 8, 2012, Pages 627-637

  Dolder, Christian R ^a,b   Nealy, Kimberly L ^a,c  

^a WINGATE UNIVERSITY   (United States)

^b Carolinas Medical Center NorthEast   (United States)

^c CAROLINAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PLACEBO; RISPERIDONE; TOPIRAMATE; ZONISAMIDE;

AGGRESSION; AGITATION; APATHY; ARTICLE; ASTHENIA; ATAXIA; CLOSED ANGLE GLAUCOMA; COGNITION; CONSTIPATION; DECREASED APPETITE; DEMENTIA; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; FATIGUE; GAIT DISORDER; HUMAN; HYPONATREMIA; IRRITABILITY; LANGUAGE DISABILITY; LETHARGY; MEMORY DISORDER; MENTAL DEFICIENCY; METABOLIC ACIDOSIS; MILD COGNITIVE IMPAIRMENT; MONOTHERAPY; NAUSEA; NEPHROLITHIASIS; PARESTHESIA; PARKINSON DISEASE; PRIORITY JOURNAL; SEDATION; SIDE EFFECT; SOMNOLENCE; SYNCOPE; TREATMENT DURATION; URINARY TRACT INFECTION; VOMITING; WEIGHT REDUCTION;

ANTICONVULSANTS; DEMENTIA; HUMANS; SAFETY;

EID: 84864130160     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11632480-000000000-00000     Document Type: Article

References (67)

1. American Psychiatric Association: Treatment of patients with Alzheimers disease and other dementias. 2nd ed. 2007 Oct [online].Available fromURL: http://psychiatryonline.org/ data/Books/prac/AlzPG101007.pdf [Accessed 2011 Oct 4]
2. American Academy of Neurology. Practice parameter: management of dementia. 2003 Oct [online]. Available from URL: http://www.neurology.org/ content/56/9/1154. full.pdf [Accessed 2011 Oct 4]
3. Lyketsos CG, Colenda CC, Beck C, et al. Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. Am J Geriatr Psychiatry 2006 Jul; 14 (7): 561-72
4. Jalbert JJ, Eaton CB, Miller SC. Antipsychotic use and the risk of hip fracture among older adults afflicted with dementia. J Am Med Dir Assoc 2010; 11: 120-7
5. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc 1999 Jan; 47 (1): 40-50
6. Mehta S, Chen H, Johnson ML, et al. Risk of falls and fractures in older adults using antipsychotic agents: a propensity- matched retrospective cohort study. Drugs Aging 2010 Oct 1; 27 (10): 815-29
7. Mehta S, Johnson ML, Chen H, et al. Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study. J Clin Psychiatry 2010 Jun; 71 (6): 689-98
8. Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested casecontrol study. BMJ 2010 Sep 21; 341: c4245
9. Rossom RC, Rector TS, Lederle FA, et al. Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia? J Am Geriatr Soc 2010 Jun; 58 (6): 1027-34
10. Schneider LS, Dagerman K, Insel PS. Efficacy and adverse effects of atypical antipsychotics for dementia: metaanalysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 2006 Mar; 14 (3): 191-210
11. United States Food and Drug Administration. Information for healthcare professionals: conventional antipsychotics. 2008 Jun 16 [online]. Available from URL: http://www. fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInforma tionforPatientsandProviders/ucm124830.htm [Accessed 2011 Feb 4]
12. Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009 Jan 15; 360 (3): 225-35
13. Bierman EJ, Comijs HC, Gundy CM, et al. The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent? Int J Geriatr Psychiatry 2007 Dec; 22 (12): 1194-200
14. Gray SL, LaCroix AZ, Hanlon JT, et al. Benzodiazepine use and physical disability in community-dwelling older adults. J Am Geriatr Soc 2006 Feb; 54 (2): 224-30
15. Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly: incidence, prevention and management. Drug Saf 1999 Aug; 21 (2): 101-22
16. Lavsa SM, Fabian TJ, Saul MI, et al. Influence of medications and diagnoses on fall risk in psychiatric inpatients. Am J Health Syst Pharm 2010 Aug; 67 (15): 1274-80
17. Wagner AK, Zhang F, Soumerai SB, et al. Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Int Med 2004 Jul 26; 164 (14): 1567-72
18. Woolcott JC, RichardsonKJ, WiensMO, et al.Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Int Med 2009 Nov 23; 169 (21): 1952-60
19. Pollock BG, Mulsant BH, Rosen J, et al. Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients.AmJ Psychiatry 2002Mar; 159 (3): 460-5
20. Pollock BG, Mulsant BH, Sweet R, et al. An open pilot study of citalopram for behavioral disturbances of dementia: plasma levels and real-time observations. Am J Geriatr Psychiatry 1997 Winter; 5 (1): 70-8
21. Dolder CR, Nealy KL, McKinsey J. Valproic acid in dementia: Does an optimal dose exist? J Pharm Pract. Epub 2011 Nov 17
22. Grossman F. A review of anticonvulsants in treating agitated demented elderly patients. Pharmacotherapy 1998 May-Jun; 18 (3): 600-6
23. Herrmann N, Lanctot KL. Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease. Can J Psychiatry 2007 Oct; 52 (10): 630-46
24. Porsteinsson AP. Divalproex sodium for the treatment of behavioural problems associated with dementia in the elderly. Drugs Aging 2006; 23 (11): 877-86
25. Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005 Feb 2; 293 (5): 596-608
26. Tariot PN, Schneider LS, Cummings J, et al. Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease. Arch Gen Psychiatry Aug; 68 (8): 853-61
27. Amann B, Pantel J, Grunze H, et al. Anticonvulsants in the treatment of aggression in the demented elderly: an update. Clin Pract Epidemiol Ment Health 2009; 5: 14
28. Guay DR. Newer antiepileptic drugs in the management of agitation/aggression in patients with dementia or developmental disability. Consult Pharm 2007 Dec; 22 (12): 1004-34
29. Sommer BR, Fenn HH, Ketter TA. Safety and efficacy of anticonvulsants in elderly patients with psychiatric disorders: oxcarbazepine, topiramate and gabapentin. Expert Opin Drug Saf 2007 Mar; 6 (2): 133-45
30. Sajatovic M, Ramsay E, Nanry K, et al. Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia. Int J Geriatr Psychiatry 2007 Oct; 22 (10): 945-50
31. Hauser WA, Morris ML, Heston LL, et al. Seizures and myoclonus in patients with Alzheimers disease. Neurology 1986 Sep; 36 (9): 1226-30
32. Hesdorffer DC, Hauser WA, Annegers JF, et al. Dementia and adult-onset unprovoked seizures. Neurology 1996 Mar; 46 (3): 727-30
33. Larner AJ. Epileptic seizures in AD patients. Neuromolecular Med 2010 Mar; 12 (1): 71-7
34. Romanelli MF, Morris JC, Ashkin K, et al. Advanced Alzheimers disease is a risk factor for late-onset seizures. Arch Neurol 1990 Aug; 47 (8): 847-50
35. Forsgren L, Bucht G, Eriksson S, et al. Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study. Epilepsia 1996 Mar; 37 (3): 224-9
36. Hommet C, Hureaux R, Barre J, et al. Epileptic seizures in clinically diagnosed Alzheimers disease: report from a geriatric medicine population. Aging Clin Exp Res 2007 Oct; 19 (5): 430-1
37. Mendez M, Lim G. Seizures in elderly patients with dementia: epidemiology and management. Drugs Aging 2003; 20 (11): 791-803
38. Rao SC, Dove G, Cascino GD, et al. Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome. Epilepsy Behav 2009 Jan; 14 (1): 118-20
39. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimers disease: recommendations from the National Institute on Aging- Alzheimers Association workgroups on diagnostic guidelines for Alzheimers disease. Alzheimers Dement 2011 May; 7 (3): 263-9
40. Ebell MH, Siwek J, Weiss BD, et al. Strength of Recommendation Taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. Am Fam Physician 2004 Feb 1; 69 (3): 548-56
41. Sommer OH, Aga O, Cvancarova M, et al. Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia. Dement Geriatr Cogn Disord 2009; 27 (2): 155-63
42. Cumbo E, Ligori LD. Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimers disease. Epilepsy Behav 2010 Apr; 17 (4): 461-6
43. Lippa CF, Rosso A, Hepler M, et al. Levetiracetam: a practical option for seizure management in elderly patients with cognitive impairment. Am J Alzheimers Dis Other Demen 2010 Mar; 25 (2): 149-54
44. Kyomen HH, Whitfield TH, Baldessarini RJ. Levetiracetam for manic behavior in hospitalized geriatric patients with dementia of the Alzheimers type. J Clin Psychopharmacol 2007 Aug; 27 (4): 408-10
45. Weiner MF, Womack KB, Martin-Cook K, et al. Levetiracetam for agitated Alzheimers disease patients. Int Psychogeriatr 2005 Jun; 17 (2): 327-8
46. Mowla A, Pani A. Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial. J Clin Psychopharmacol 2010 Feb; 30 (1): 40-3
47. Fhager B, Meiri IM, Sjogren M, et al. Treatment of aggressive behavior in dementia with the anticonvulsant topiramate: a retrospective pilot study. Int Psychogeriatr 2003 Sep; 15 (3): 307-9
48. Odawara T, Shiozaki K, Togo T, et al. Administration of zonisamide in three cases of dementia with Lewy bodies. Psychiatry Clin Neurosci 2010 Jun; 64 (3): 327-9
49. Sato S, Mizukami K, Asada T. Successful treatment of extrapyramidal and psychotic symptoms with zonisamide in a patient with dementia with Lewy bodies. Prog Neuropsychopharmacol Biol Psychiatry 2010 Aug 16; 34 (6): 1130-1
50. Belcastro V, Costa C, Galletti F, et al. Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study. Eur J Neurol 2007 Oct; 14 (10): 1176-8
51. Zesiewicz TA, Sullivan KL, Hauser RA, et al. Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntingtons disease. Mov Disord 2006 Nov; 21 (11): 1998-2001
52. US National Institutes of Health. ClinicalTrials.gov [online]. Available from URL: http://www.clinicaltrials.gov [Accessed 2011 Oct 4]
53. Kutluay E, McCague K, DSouza J, et al. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav 2003 Apr; 4 (2): 175-80
54. Chapman IM. Weight loss in older persons. Med Clin North Am 2011 May; 95 (3): 579-93, xi
55. Murata M, Hasegawa K, Kanazawa I. Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study. Neurology 2007 Jan 2; 68 (1): 45-50
56. Aldenkamp AP, De Krom M, Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia 2003; 44 Suppl. 4: 21-9
57. Sempere AP, Medrano V, Berenguer-Ruiz L. Reversible dementia secondary to topiramate. Clin Neuropharmacol 2008 Jan-Feb; 31 (1): 62
58. Lexicomp Online [subscription, online database]. Hudson (OH): Lexi-Comp, Inc., 2012 [online]. Available from URL: http://www.lexi.com [Accessed 2011 Feb 4]
59. Cicolin A, Magliola U, Giordano A, et al. Effects of levetiracetam on nocturnal sleep and daytime vigilance in healthy volunteers. Epilepsia 2006 Jan; 47 (1): 82-5
60. Meador KJ. Cognitive and memory effects of the new antiepileptic drugs. Epilepsy Res 2006 Jan; 68 (1): 63-7
61. Perucca E. Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age. Clin Pharmacokinet 2006; 45 (4): 351-63
62. Neyens LG, Alpherts WC, Aldenkamp AP. Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy. Prog Neuropsychopharmacol Biol Psychiatry 1995 May; 19 (3): 411-9
63. Alsaadi TM, Koopmans S, Apperson M, et al. Levetiracetam monotherapy for elderly patients with epilepsy. Seizure 2004 Jan; 13 (1): 58-60
64. Cramer JA, Leppik IE, Rue KD, et al. Tolerability of levetiracetam in elderly patients with CNS disorders. Epilepsy Res 2003 Oct; 56 (2-3): 135-45
65. Chengappa KN, Rathore D, Levine J, et al. Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disord 1999 Sep; 1 (1): 42-53
66. White HS, Brown SD, Woodhead JH, et al. Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia 2000; 41 Suppl. 1: S17-20
67. Mitchell PB, Malhi GS. The expanding pharmacopoeia for bipolar disorder. Annu Rev Med 2002; 53: 173-88